{"url_path":"/sec/bicx/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 LEGAL PROCEEDINGS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1443863/0001477932-26-003159-index.html","accession_number":"0001477932-26-003159","cik":"0001443863","ticker":"BICX","issuer_name":"BioCorRx Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1443863/0001477932-26-003159-index.html","primary_entity_key":"0001443863","primary_entity_name":"BioCorRx Inc."},"word_count":290,"has_tables":true,"body_markdown":"ITEM 1. LEGAL PROCEEDINGS\n\n \n\n(1) \n\nThe Company initiated litigation in 2019 based on a claim that Pellecome and Dr. Orbeck utilized the Company’s confidential information to advance their own weight loss product.\n\n \n\nThe Company dismissed this litigation without prejudice in July 2021.\n\n \n\nOn March 30, 2022, the court entered judgment in favor of Pellecome as an individual defendant whereby the Company was ordered to pay Pellecome total costs and attorneys’ fees of $235,886. Pursuant to the judgment, this amount is accruing interest at the rate of ten percent (10%) per annum from October 6, 2021 (the date of the original award of attorneys’ fees by the court which was followed by a number of filings by each party through February 2022).\n\n \n\nOn May 27, 2022, the Company filed a notice of appeal with California Superior Court for Orange County regarding the March 30, 2022 judgment entered in favor of Pellecome. On February 2, 2023, the Company filed a motion requesting the California Superior Court for Orange County reverse and remand its prior ruling, including reversing the granting of Pellecome $222,933 in attorney’s fees. On October 4, 2023 the Court of Appeal of the State of California upheld the March 30, 2022 judgement in favor of Pellecome whereby $222,933 was awarded in attorney’s fees. On January 5, 2024 the California Superior Court for Orange County entered an amended judgement of $332,503 in favor of Pellecome for costs and attorneys’ fees, in addition to the $332,503 judgement the Company owes accrued interest of $94,816. On March 11, 2025, the Company entered into a settlement agreement with Pellecome (the “Settlement Agreement”) pursuant to which the Company shall pay to Pellecome $418,000 to settle the claims. As of March 31, 2026, $76,500 remains outstanding."}